相关实验视频

Updated: Jul 16, 2026

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

在小鼠中,SMYD2抑制剂对改善非酒精性脂肪肝炎无影响

Lanzexin Yang¹, Shixuan Zhuo¹, Xinyu Zhu²

¹Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China.

Frontiers in endocrinology

|June 20, 2025

概括

在小鼠模型中,SMYD2抑制剂AZ505和LLY-507没有改善非酒精性脂肪肝炎 (NASH). 这些发现表明,抑制SMYD2不是治疗NASH的可行治疗策略.

科学领域:

肝病学肝病学是一种肝病学.
分子生物学分子生物学
药理学药理学是指药理学的学科.

背景情况:

非酒精性脂肪肝炎 (NASH) 是一种进展性肝脏疾病,全球流行率越来越高.
迫切需要对NASH进行有效的药物治疗.
以前的研究表明,SMYD2抑制在肝硬化症中起着保护作用.

研究的目的:

在NASH的小鼠模型中评估SMYD2抑制剂AZ505和LLY-507的治疗潜力.
研究SMYD2抑制在减轻与NASH相关的肝损伤,炎症和纤维化方面的疗效.

主要方法:

通过使用胆缺乏,高脂肪饮食 (CDAHFD) 建立了NASH的小鼠模型.
小鼠通过腹腔内注射接受SMYD2抑制剂AZ505和LLY-507的治疗.
进行了生物化学和组织学分析,以评估NASH参数和治疗效果.

主要成果:

在肝脏样本中,SMYD2抑制剂AZ505和LLY-507证实抑制了组织素甲基化.
在小鼠模型中,CDAHFD成功诱导肝纤维化和炎症.
用AZ505和LLY-507治疗并没有改善NASH得分,肝损伤,纤维化或炎症.

结论:

用AZ505和LLY-507抑制SMYD2在NASH小鼠模型中未能证明治疗效益.
这些发现表明,针对SMYD2可能不是治疗NASH的有效策略.
需要进一步的研究来探索NASH的替代治疗点.

关键词:

这就是SMYD2的原因.纤维化纤维化肝脏肥胖症肝脏肥胖症这是一种炎症炎症炎症炎症.肝脏损伤肝脏损伤是什么?非酒精性型肝炎的疾病.

更多相关视频

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution

Published on: April 16, 2019

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes

Published on: April 26, 2019

相关概念视频

Inhibitors of Viral Protein Synthesis

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...